Nitin Khanna has been involved in the tech world for the past few decades and has repeatedly gone from success to success. As the founder and former CEO of Saber Corp, he’s gone from running one multi-million dollar company to another and another. Nitin Khanna founded the company in 1998 and by 2008 it was generating a yearly revenue of $120 million with a staff of over 1,200. The company was eventually sold to EDS and Mr. Khanna.
During that time, the company grew to a revenue of $300 million and a staff of 1,500. However, after a year Nitin Khanna left to found MergerTech; the boutique technology bank not only provides investment to tech companies but a number of M&A advices. Mr. Khanna also founded Cura Cannabis in 2015 which has quickly become one of the leading cannabis oil providers in Oregon. See more here about Cura Cannabis here https://medium.com/@NitinKhannaCeo/nitin-khanna-riding-the-cannabis-wave-with-cura-cannabis-solutions-9fcf612ee529. Furthermore, he sits on the boards of Freewire Broadband, Vendscreen, the Classic Wines Auction and TiE Oregon.
Throughout all of this, Nitin Khanna has brought a unique philosophy to each of his roles. As Nitin puts is, he’s far from a traditionalist and likes to see as many perspectives and approaches to problems that he can. Because of that, he and MergerTech rarely go the route that’s been tried and tested. Mr. Khanna has also said that he’s curious by nature and he sees it as one of his biggest strengths. This approach has brought in some great results for his businesses. He’s also noted that in order to be successful, you have to be flexible with your approach; because of his curiosity, his businesses may sometimes go down a path that doesn’t seem to be leading to success.
With that in mind, flexibility and adaptability are important parts of Nitin Khanna’s approach to doing business, both with his investment partners through MergerTech and with every other business he’s a part of. He’s also noted that planning as much as possible is one of the secrets to his success and that you can never over plan your business, provided you’re adaptable once it’s set in motion.
Follow Nitin here.
In 1987 Marc Beer walked out of the University of Miami with a Bachelor’s of Science Degree and he never looked back. Instead, he focused on biotechnology, pharmaceuticals, devices, and diagnostics with a specialization in developing these further and commercializing them so the consumer understood how it would make both their lives and the lives of their children better.
One of his biggest accomplishments includes becoming the founding CEO of ViaCell, which specializes in preserving stem cells from umbilical cords. He not only kept the company growing but made it thrive.
And now he’s using his company Renovia Inc. to help the pelvic floor at Boston Women’s Health. This plan cost about thirty-two million dollars in Series B along with ten million in venture debt. The exciting thing about this venture with Boston Women’s Health is that the money will be spent with the goal to improve the lives of women in the community who struggle with silent disorders. With the money, they are developing both diagnostic and therapeutic products to help people with issues such as urinary incontinence. Urinary incontinence is a problem that affects two hundred and fifty million women worldwide. The venture’s first product received FDA approval in April, giving women who are already in Boston Women’s some relief already.
Several companies saw and believed in what Renovia Inc. was doing and backed them up. These companies include the Longwood Firm, New York’s Perceptive Advisors, and Missouri’s Ascension Ventures. Their funding will help further the goal of relief by testing out four more diagnostic and therapeutic products, including a new generation of the Leva device.
The Leva device is a digital health program that uses Bluetooth to give interactive visualization to women, giving them real-time progress tracking, helping them strengthen and rehabilitate weak pelvic muscles. It does this without surgery or medicine.
Marc Beer stated that the goal for the funding and devices is to, “give our customers valuable data to inform new treatment options, drive greater knowledge and understanding of pelvic floor disorders, and ultimately lower long-term healthcare costs.” Something, it seems, everyone can get behind. Learn more: https://www.slideshare.net/MarcBeer